C.M. Bidwell & Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$893 Hold
225
– – ﹤0.01% 438
2026
Q2
$947 Buy
+225
New +$867 ﹤0.01% 443
2021
Q4
– Sell
-6,360
Closed -$83K – 588
2021
Q3
$83K Buy
+6,360
New +$82.2K 0.06% 249

Other funds holding IRWD

C.M. Bidwell & Associates's IRWD Position: Q3 2026 in Review

C.M. Bidwell & Associates held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2026 at 225 shares worth $893. The position accounts for ﹤0.01% of the portfolio, ranked #438.

C.M. Bidwell & Associates first reported a position in IRWD in Q3 2021 and has held it in 3 quarters since. The position peaked at $83K in Q3 2021. 234 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • C.M. Bidwell & Associates held 225 shares of Ironwood Pharmaceuticals worth $893 as of Q3 2026.
  • C.M. Bidwell & Associates left its Ironwood Pharmaceuticals share count unchanged in Q3 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q3 2026, its #438 holding.
  • C.M. Bidwell & Associates first reported a position in Ironwood Pharmaceuticals in Q3 2021 and has held it in 3 quarters since.
  • C.M. Bidwell & Associates's Ironwood Pharmaceuticals position peaked at $83K in Q3 2021.
  • 234 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2026, filed 17 Nov 2026.